MedPath

Analysis of molecular mechanism of systemic bone metabolism abnormality in systemic autoimmune diseases

Not Applicable
Recruiting
Conditions
Rheumatic disease
Registration Number
JPRN-UMIN000026431
Lead Sponsor
Saitama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients and healthy volunteers who are more than 80 years old at enrollment 2) patients and healthy volunteers whom the investigator considers to be unsuitable for the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The number of osteoclasts and osteoclast-like cells differentiated from peripheral blood mononuclear cells in rheumatic disease patients and healthy volunteers.
Secondary Outcome Measures
NameTimeMethod
The differentiation-inducing factor of osteoclasts and osteoclast-like cells.
© Copyright 2025. All Rights Reserved by MedPath